Fig. 1From: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV eventsCMV-TCIP flow images for CD4+ (top) and CD8+ (bottom) populations demonstrating CMV-specific response (left) or no response (right). IFNG: Interferon-gammaBack to article page